DK1890684T3 - Behandling af søvn/vågenhedsforstyrrelser - Google Patents
Behandling af søvn/vågenhedsforstyrrelserInfo
- Publication number
- DK1890684T3 DK1890684T3 DK06772647.1T DK06772647T DK1890684T3 DK 1890684 T3 DK1890684 T3 DK 1890684T3 DK 06772647 T DK06772647 T DK 06772647T DK 1890684 T3 DK1890684 T3 DK 1890684T3
- Authority
- DK
- Denmark
- Prior art keywords
- sleep
- treatment
- wakefulness disorders
- wakefulness
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68863805P | 2005-06-08 | 2005-06-08 | |
| PCT/US2006/022407 WO2006133393A1 (en) | 2005-06-08 | 2006-06-07 | Treatment of sleep-wake disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1890684T3 true DK1890684T3 (da) | 2013-10-14 |
Family
ID=37085728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06772647.1T DK1890684T3 (da) | 2005-06-08 | 2006-06-07 | Behandling af søvn/vågenhedsforstyrrelser |
Country Status (17)
| Country | Link |
|---|---|
| US (8) | US8440715B2 (show.php) |
| EP (1) | EP1890684B1 (show.php) |
| JP (1) | JP5024635B2 (show.php) |
| KR (1) | KR101335941B1 (show.php) |
| CN (1) | CN101217949B (show.php) |
| AU (1) | AU2006254899B2 (show.php) |
| BE (1) | BE2020C004I2 (show.php) |
| BR (1) | BRPI0613697A2 (show.php) |
| CA (1) | CA2611713C (show.php) |
| DK (1) | DK1890684T3 (show.php) |
| ES (1) | ES2435403T3 (show.php) |
| FR (1) | FR20C1014I2 (show.php) |
| NL (1) | NL301037I2 (show.php) |
| PL (1) | PL1890684T3 (show.php) |
| RU (1) | RU2417077C2 (show.php) |
| TW (2) | TW201328689A (show.php) |
| WO (1) | WO2006133393A1 (show.php) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0613697A2 (pt) | 2005-06-08 | 2011-01-25 | Sk Holdings Co Ltd | tratamento de distúrbios de sono-vigìlia |
| ES2344469T3 (es) * | 2005-06-22 | 2010-08-27 | Sk Holdings Co., Ltd. | Tratamiento de disfuncion sexual. |
| KR102021075B1 (ko) * | 2009-06-22 | 2019-11-04 | 에스케이바이오팜 주식회사 | 피로의 치료 또는 예방 방법 |
| US8232315B2 (en) * | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| WO2011055944A2 (en) * | 2009-11-06 | 2011-05-12 | Sk Holdings Co., Ltd. | Methods for treating fibromyalgia syndrome |
| BR112012010670A2 (pt) * | 2009-11-06 | 2016-04-12 | Sk Biopharmaceuticals Co Ltd | métodos para tratamento de distúrbio de défict de atenção/hiperatividade |
| US8623913B2 (en) * | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| MY177740A (en) | 2013-03-13 | 2020-09-23 | Sk Biopharmaceuticals Co Ltd | Treatment of cataplexy |
| TW201919605A (zh) | 2013-07-18 | 2019-06-01 | 南韓商愛思開生物製藥股份有限公司 | 肥胖之治療 |
| US10888542B2 (en) | 2014-02-28 | 2021-01-12 | Sk Biopharmaceuticals Co., Ltd. | Aminocarbonylcarbamate compounds |
| TWI698415B (zh) | 2014-02-28 | 2020-07-11 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
| WO2016061488A1 (en) * | 2014-10-17 | 2016-04-21 | Concert Pharmaceuticals, Inc. | Amine reuptake inhibitors |
| JP6466792B2 (ja) * | 2015-07-03 | 2019-02-06 | エスケー バイオファーマスティカルズ カンパニー リミテッド | 注意欠陥／多動性障害（ａｄｈｄ）の治療方法 |
| TWI637765B (zh) * | 2016-05-10 | 2018-10-11 | 台灣共振波研發股份有限公司 | Soothing device for attention deficit hyperactivity disorder |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| CN121202730A (zh) * | 2016-09-06 | 2025-12-26 | 爱尔兰贾兹制药有限公司 | (r)-2-氨基-3-苯丙基氨基甲酸酯盐酸盐的制备方法、其组合物及用途 |
| WO2018067971A1 (en) * | 2016-10-06 | 2018-04-12 | Jazz Pharmaceuticals International Iii Limited | Carbamoyl phenylalaninol compounds and uses therof |
| BR112019025286A2 (pt) * | 2017-06-02 | 2020-06-23 | Jazz Pharmaceuticals Ireland Limited | Métodos e composições para tratamento de sonolência excessiva |
| CA3071779A1 (en) * | 2017-07-31 | 2019-02-07 | Jazz Pharmaceuticals Ireland Limited | Carbamoyl phenylalaninol analogs and uses thereof |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
| US11033214B1 (en) * | 2020-05-19 | 2021-06-15 | United Arab Emirates University | Wearable eye tracking system |
| KR102390194B1 (ko) | 2020-08-03 | 2022-04-25 | 셀라이온바이오메드 주식회사 | 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물 |
| EP4615426A1 (en) * | 2022-11-07 | 2025-09-17 | Axsome Therapeutics | Compositions and methods for treating insomnia |
| WO2024118904A1 (en) * | 2022-11-30 | 2024-06-06 | Axsome Therapeutics | Methods and compositions for improving driving performance |
| WO2025006965A1 (en) | 2023-06-29 | 2025-01-02 | Axsome Therapeutics, Inc. | Methods of administering solriamfetol to lactating women |
| WO2025165760A1 (en) * | 2024-01-29 | 2025-08-07 | Axsome Therapeutics, Inc. | Phenylalkylamino carbamates for use in the treatment of attention deficit/hyperactivity disorder |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2939660A1 (de) * | 1979-09-29 | 1981-04-16 | Basf Ag, 6700 Ludwigshafen | Neue carbamate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen |
| NZ260667A (en) | 1993-06-10 | 1997-05-26 | Lilly Co Eli | Preventing emesis or treating sexual dysfunction using tetrahydrobenz[cd]indole 6-carboxamides |
| KR100197892B1 (ko) | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
| US5756817C1 (en) * | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
| KR0173862B1 (ko) | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| KR0173863B1 (ko) | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| CN1076016C (zh) * | 1996-10-10 | 2001-12-12 | Sk株式会社 | O－氨基甲酰基－苯丙胺醇化合物、其药学上有用的盐和它们的制备方法 |
| WO1998017636A1 (en) | 1996-10-22 | 1998-04-30 | Ortho Pharmaceutical Corporation | Phenylalaninol derivatives for the treatment of central nervous system disorders |
| ES2262826T3 (es) * | 2001-02-27 | 2006-12-01 | Ortho-Mcneil Pharmaceutical, Inc. | Uso de un compuesto de carbamato en la prevencion o el tratamiento de transtornos de ansiedad. |
| RU2300372C2 (ru) * | 2001-02-27 | 2007-06-10 | Орто-Макнейл Фармасьютикал, Инк. | Карбаматы для применения для предотвращения или лечения биполярного расстройства |
| PT1411917E (pt) * | 2001-02-27 | 2007-09-17 | Ortho Mcneil Pharm Inc | ''compostos carbamatos para utilização na prevenção ou tratamento de distúrbios do movimento'' |
| US20050080268A1 (en) | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
| US20050203130A1 (en) * | 2003-12-02 | 2005-09-15 | Erik Buntinx | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
| BRPI0518233A2 (pt) | 2004-10-28 | 2008-11-11 | Sk Corp | terapia adjunta para depressço |
| BRPI0613697A2 (pt) * | 2005-06-08 | 2011-01-25 | Sk Holdings Co Ltd | tratamento de distúrbios de sono-vigìlia |
| ES2344469T3 (es) | 2005-06-22 | 2010-08-27 | Sk Holdings Co., Ltd. | Tratamiento de disfuncion sexual. |
| CN101272776B (zh) | 2005-07-26 | 2012-10-03 | 詹森药业有限公司 | 氨基甲酸酯在制备治疗物质滥用相关疾病药物中的用途 |
| EA200970377A1 (ru) | 2006-10-13 | 2009-10-30 | Янссен Фармацевтика Нв | Композиции фенилалкиламинокарбамата |
| KR102021075B1 (ko) | 2009-06-22 | 2019-11-04 | 에스케이바이오팜 주식회사 | 피로의 치료 또는 예방 방법 |
| US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| WO2011055944A2 (en) | 2009-11-06 | 2011-05-12 | Sk Holdings Co., Ltd. | Methods for treating fibromyalgia syndrome |
| BR112012010670A2 (pt) | 2009-11-06 | 2016-04-12 | Sk Biopharmaceuticals Co Ltd | métodos para tratamento de distúrbio de défict de atenção/hiperatividade |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| KR102005483B1 (ko) | 2012-10-19 | 2019-07-31 | 삼성디스플레이 주식회사 | 박막 트랜지스터 기판 및 그의 수리 방법 |
| MY177740A (en) * | 2013-03-13 | 2020-09-23 | Sk Biopharmaceuticals Co Ltd | Treatment of cataplexy |
-
2006
- 2006-06-07 BR BRPI0613697-4A patent/BRPI0613697A2/pt not_active Application Discontinuation
- 2006-06-07 CN CN2006800253545A patent/CN101217949B/zh active Active
- 2006-06-07 WO PCT/US2006/022407 patent/WO2006133393A1/en not_active Ceased
- 2006-06-07 RU RU2008100019/15A patent/RU2417077C2/ru active
- 2006-06-07 US US11/921,995 patent/US8440715B2/en active Active
- 2006-06-07 ES ES06772647T patent/ES2435403T3/es active Active
- 2006-06-07 JP JP2008515949A patent/JP5024635B2/ja active Active
- 2006-06-07 PL PL06772647T patent/PL1890684T3/pl unknown
- 2006-06-07 KR KR1020087000522A patent/KR101335941B1/ko active Active
- 2006-06-07 TW TW101130937A patent/TW201328689A/zh unknown
- 2006-06-07 DK DK06772647.1T patent/DK1890684T3/da active
- 2006-06-07 CA CA2611713A patent/CA2611713C/en not_active Expired - Fee Related
- 2006-06-07 AU AU2006254899A patent/AU2006254899B2/en active Active
- 2006-06-07 TW TW095120134A patent/TWI419681B/zh active
- 2006-06-07 EP EP06772647.1A patent/EP1890684B1/en active Active
-
2013
- 2013-01-23 US US13/747,508 patent/US8877806B2/en active Active
-
2014
- 2014-08-06 US US14/452,816 patent/US9604917B2/en active Active
-
2017
- 2017-02-15 US US15/433,660 patent/US10351517B2/en active Active
-
2019
- 2019-05-23 US US16/420,834 patent/US20190367448A1/en not_active Abandoned
-
2020
- 2020-03-30 NL NL301037C patent/NL301037I2/nl unknown
- 2020-04-16 FR FR20C1014C patent/FR20C1014I2/fr active Active
- 2020-05-07 BE BE2020C004C patent/BE2020C004I2/nl unknown
- 2020-09-28 US US17/034,564 patent/US11753368B2/en active Active
-
2023
- 2023-08-03 US US18/364,689 patent/US12209059B2/en active Active
-
2024
- 2024-12-13 US US18/979,843 patent/US20250109099A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1890684T3 (da) | Behandling af søvn/vågenhedsforstyrrelser | |
| HUS1600048I1 (hu) | Készítmény Fabry-kór kezelésére | |
| DK1720866T3 (da) | Fremgangsmåde | |
| EP1845849A4 (en) | EXISCELET FOR THE LEGS | |
| EP1874239A4 (en) | HALF-POWERED EXOSCELETT OF LOWER EXTREMITY | |
| PT2444424T (pt) | Nanocorpos tm aperfeiçoados para o tratamento de distúrbios mediados por agregação | |
| DK2056807T3 (da) | Behandling af inflammatoriske sygdomme | |
| DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
| DK1874781T3 (da) | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme | |
| DK1938528T3 (da) | Provision af qos-behandling baseret på flere anmodninger | |
| NO20070251A (no) | Brønnbehandling | |
| NO20070297A (no) | Brønnbehandling | |
| DK1708992T3 (da) | Sulfonamidderivater til behandling af sygdomme | |
| BRPI0816712A2 (pt) | terapia de intervalo para o tratamento de tinnitus | |
| ATE521238T1 (de) | Kristalline modifikationen des pyraclostrobins | |
| BRPI0815551A2 (pt) | Tratamento através de hucbc de doença beta-amiloide | |
| DK1937633T3 (da) | Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme | |
| PL1708991T3 (pl) | Pochodne sulfonoamidu do leczenia chorób | |
| DK1685834T3 (da) | Anvendelse af pinolensyre til behandling af obesitet | |
| DK2056858T3 (da) | Behandling af lungesygdomstilstande | |
| DK1491212T3 (da) | Middel til behandling af søvnforstyrrelser | |
| BRPI0715728A8 (pt) | tratamento de distúrbios cartilaginosos | |
| DK1863899T3 (da) | Hudbehandlingspræparater | |
| BRPI0818121A2 (pt) | diespiro 1,2,4-trioxolano e seus métodos de fabricação e utilização | |
| DK1962869T3 (da) | Behandling af luftvejssygdomme |